Adient PLC has a consensus price target of $30.71 based on the ratings of 16 analysts. The high is $62 issued by Benchmark on August 7, 2023. The low is $19 issued by Morgan Stanley on November 14, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, B of A Securities, and Morgan Stanley on December 16, 2024, November 21, 2024, and November 14, 2024, respectively. With an average price target of $21 between Wells Fargo, B of A Securities, and Morgan Stanley, there's an implied 25.37% upside for Adient PLC from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Adient (NYSE:ADNT) was reported by Wells Fargo on December 16, 2024. The analyst firm set a price target for $20.00 expecting ADNT to rise to within 12 months (a possible 19.40% upside). 31 analyst firms have reported ratings in the last year.
The latest analyst rating for Adient (NYSE:ADNT) was provided by Wells Fargo, and Adient downgraded their equal-weight rating.
The last upgrade for Adient PLC happened on July 1, 2024 when Exane BNP Paribas raised their price target to $26. Exane BNP Paribas previously had an underperform for Adient PLC.
The last downgrade for Adient PLC happened on December 16, 2024 when Wells Fargo changed their price target from $27 to $20 for Adient PLC.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Adient, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Adient was filed on December 16, 2024 so you should expect the next rating to be made available sometime around December 16, 2025.
While ratings are subjective and will change, the latest Adient (ADNT) rating was a downgraded with a price target of $27.00 to $20.00. The current price Adient (ADNT) is trading at is $16.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.